DK269885A - 4-(aryl eller heteroaryl)-2-(heteroarylalkoxymethyl)-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere og farmaceutiske praeparater indeholdende disse - Google Patents

4-(aryl eller heteroaryl)-2-(heteroarylalkoxymethyl)-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere og farmaceutiske praeparater indeholdende disse Download PDF

Info

Publication number
DK269885A
DK269885A DK269885A DK269885A DK269885A DK 269885 A DK269885 A DK 269885A DK 269885 A DK269885 A DK 269885A DK 269885 A DK269885 A DK 269885A DK 269885 A DK269885 A DK 269885A
Authority
DK
Denmark
Prior art keywords
heteroarylalcoxymethyl
dihydropyridine
heteroaryl
aryl
methyl
Prior art date
Application number
DK269885A
Other languages
Danish (da)
English (en)
Other versions
DK269885D0 (da
Inventor
David Alker
Simon Fraser Campbell
Peter Edward Cross
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK269885D0 publication Critical patent/DK269885D0/da
Publication of DK269885A publication Critical patent/DK269885A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
DK269885A 1984-06-15 1985-06-14 4-(aryl eller heteroaryl)-2-(heteroarylalkoxymethyl)-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere og farmaceutiske praeparater indeholdende disse DK269885A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848415386A GB8415386D0 (en) 1984-06-15 1984-06-15 Therapeutic agents

Publications (2)

Publication Number Publication Date
DK269885D0 DK269885D0 (da) 1985-06-14
DK269885A true DK269885A (da) 1985-12-16

Family

ID=10562530

Family Applications (1)

Application Number Title Priority Date Filing Date
DK269885A DK269885A (da) 1984-06-15 1985-06-14 4-(aryl eller heteroaryl)-2-(heteroarylalkoxymethyl)-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere og farmaceutiske praeparater indeholdende disse

Country Status (11)

Country Link
EP (1) EP0165032A3 (fi)
JP (1) JPS617276A (fi)
KR (1) KR860000285A (fi)
AU (1) AU4368985A (fi)
DK (1) DK269885A (fi)
FI (1) FI852340L (fi)
GB (1) GB8415386D0 (fi)
GR (1) GR851447B (fi)
HU (1) HUT37934A (fi)
IL (1) IL75507A0 (fi)
PT (1) PT80630B (fi)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1213555B (it) * 1986-12-11 1989-12-20 Boehringer Biochemia Srl 2 metiltiometildiidropiridine, un processo per laloro preparazione e composizioni farmaceutiche che le contengono.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7910521L (sv) * 1979-12-20 1981-06-21 Haessle Ab Nya 2-metyl-6-substituerade-4-(2,3-disubstituerad fenyl)-1,4-dihydropyridin-3,5-diestrar med hypotesiva egenskaper, samt forfarande for deras framstellning, och farmaceutiska beredningar innehallande desamma
CS228917B2 (en) * 1981-03-14 1984-05-14 Pfizer Method of preparing substituted derivatives of 1,4-dihydropyridine
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
DE3207982A1 (de) * 1982-03-05 1983-09-08 Bayer Ag, 5090 Leverkusen Neue 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihrer verwendung in arzneimitteln
DE3363743D1 (en) * 1982-07-22 1986-07-03 Pfizer Ltd Dihydropyridine anti-ischaemic and antihypertensive agents
EP0107293A3 (en) * 1982-09-04 1984-06-06 Pfizer Limited Dihydropyridines
PH19166A (en) * 1982-09-04 1986-01-16 Pfizer Dihydropyridined,pharmaceutical compositions and method of use
US4515799A (en) * 1983-02-02 1985-05-07 Pfizer Inc. Dihydropyridine anti-ischaemic and antihypertensive agents

Also Published As

Publication number Publication date
PT80630A (en) 1985-07-01
PT80630B (en) 1987-04-28
KR860000285A (ko) 1986-01-27
GB8415386D0 (en) 1984-07-18
EP0165032A3 (en) 1987-06-16
IL75507A0 (en) 1985-10-31
AU4368985A (en) 1985-12-19
GR851447B (fi) 1985-11-25
FI852340A0 (fi) 1985-06-12
JPS617276A (ja) 1986-01-13
DK269885D0 (da) 1985-06-14
EP0165032A2 (en) 1985-12-18
FI852340L (fi) 1985-12-16
HUT37934A (en) 1986-03-28

Similar Documents

Publication Publication Date Title
DK160985C (da) Asymmetriske diestere af 1,4-dihydro-2,6-dimethyl-pyridin-3,5-dicarboxylsyre, fremgangsmaader til fremstilling heraf samt farmaceutiske praeparater indeholdende disse
DK8985A (da) 4-((bicyklisk heterocyclyl)-methyl og -hetero)-piperidin-derivater ogfremgangsmaade til fremstilling deraf
NL980037I2 (nl) 4-(Ortho-gesubstitueerd fenyl)-1,4-dihydro-2,6-dialyl-3,5-pyridinedicarbonzuur diesterderivaten met antihypertensieve werking en farmaceutisch preparaat dat deze bevat.
DK154085D0 (da) N-aryl-n-(4-piperidinyl)-amider samt farmaceutiske praeparater deraf
IT8520716A0 (it) Fosfato di zirconio e suo metodo di preparazione.
DK290986D0 (da) 2-arylimidazolforbindelser, laegemidler indeholdende disse forbindelser og deres fremstilling
DK474684D0 (da) 1-benzylaminoalkylpyrrolidinoner, syreadditionssalte deraf, fremgangsmaade til deres fremstilling og laegemidler indeholdende disse
KR870700608A (ko) 아미노-살리실산 유도체 및 제약 조성물
NO166792C (no) Sialinsyrederivater og bindemiddel inneholdende slike.
DK553988A (da) 4-aminopyridin-derivater og farmaceutiske praeparater indeholdende disse
DK374185A (da) 1,4-dihydropyridiner eller salte deraf og farmaceutiske praeparater indeholdende dem
DK48886D0 (da) Akryl- eller heteroarylforbindelse og farmaceutisk praeparat indeholdende en saadan forbindelse
DK272784A (da) 1,4-dihydropyridin-derivat, fremgangsmaade til fremstilling og farmaceutisk anvendelse deraf
NL8601011A (nl) 7-amino-3-propenylcefalosporanzuur en esters daarvan.
DK253585A (da) Heterocyclisk substituerede 1,4-dihydropyridin-derivater og farmaceutiske praeparater indeholdende disse derivater
DK269885D0 (da) 4-(aryl eller heteroaryl)-2-(heteroarylalkoxymethyl)-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere og farmaceutiske praeparater indeholdende disse
DK433787A (da) 1-phenylquinazolin-1h,3h-2,4-dioner og 1-phenylpyrido oe2,3-daapyrimidin-1h,3h-dioner, estere og syreadditionssalte deraf samt farmaceutiske midler indeholdende saadanne forbindelser
DK449989D0 (da) Quinolinderivater, deres fremstilling og laegemidler indeholdende disse derivater
DK65686D0 (da) Dihydropyridiner, fremgangsmaade til fremstilling heraf samt farmaceutiske midler indeholdende disse
DK344384D0 (da) 2-heterocyclylalkylthio-6-(alfa-hydroxyethyl)-2-penem-3-carboxylsyre-forbindelser og farmaceutiske praeparater indeholdende disse
DK22286D0 (da) 1,4-dihydropyridin-derivater og farmaceutiske praeparater indeholdende disse
DK65586D0 (da) Dihydropyridiner, fremgangsmaade til fremstilling heraf samt farmaceutiske midler indeholdende disse
AT397657B (de) Nucleinsäurederivate
KR880701228A (ko) 2- 메틸-1,4- 디히드로피리딘, 그의 제조방법 및 이 화합물을 함유하는 제약 조성물
DK626487D0 (da) Oliesyreestre og farmaceutiske kompositioner

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment